Moreover, in a retrospective study that included 136 advanced lung cancer patients receiving a PD-1/PD-L1 inhibitor combined chemotherapy, high plasma HSP90α was an independent prognostic predictor for poor PFS and OS 31. The gene discussed is HSP90AA1; the disease is lung carcinoma.